Hologic (HOLX) PT Raised to $95 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Hologic (HOLX) Tops Q3 EPS by 4c, provides guidance
July 29, 2024 4:04 PM EDTHologic (NASDAQ: HOLX) reported Q3 EPS of $1.06, $0.04 better than the analyst estimate of $1.02. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1 billion.
GUIDANCE:
Hologic sees FY2024 EPS of $4.04-$4.11, versus the consensus of $4.07. Hologic sees... More



